Kingsview Wealth Management, LLC Immuneering Corp Transaction History
Kingsview Wealth Management, LLC
- $5.28 Billion
- Q2 2025
A detailed history of Kingsview Wealth Management, LLC transactions in Immuneering Corp stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 14,000 shares of IMRX stock, worth $81,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000Holding current value
$81,760% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMRX
# of Institutions
42Shares Held
3.81MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$6.17 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0574KShares$3.35 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$3.11 Million0.0% of portfolio
-
Southport Management, L.L.C. Wilson, WY245KShares$1.43 Million4.03% of portfolio
-
Geode Capital Management, LLC Boston, MA230KShares$1.34 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $154M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...